Jump Trading’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-7,361
Closed -$803K 307
2019
Q2
$803K Buy
+7,361
New +$783K 0.04% 111
2018
Q1
Sell
-200
Closed -$22.2K 396
2017
Q4
$21K Buy
200
+185
+1,233% +$19.8K ﹤0.01% 369
2017
Q3
$2K Sell
15
-6,198
-100% -$662K ﹤0.01% 277
2017
Q2
$642K Buy
+6,213
New +$612K 0.09% 160
2017
Q1
Sell
-681
Closed -$65.2K 233
2016
Q4
$60K Sell
681
-7,716
-92% -$702K 0.02% 129
2016
Q3
$810K Sell
8,397
-61,230
-88% -$5.82M 0.09% 75
2016
Q2
$5.97M Buy
+69,627
New +$6.25M 0.26% 39
2014
Q3
Sell
-20,850
Closed -$1.83M 1264
2014
Q2
$1.79M Buy
+20,850
New +$1.64M 0.08% 91

Other funds holding IBB

Jump Trading's IBB Position: Q3 2019 in Review

Jump Trading sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 7,361 shares — an estimated $803K sold.

Jump Trading first reported a position in IBB in Q2 2014 and held it in 8 quarters. The position peaked at $5.97M in Q2 2016. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Jump Trading reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • Jump Trading sold 7,361 iShares Biotechnology ETF shares in Q3 2019, an estimated $803K.
  • Jump Trading first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 8 quarters.
  • Jump Trading's iShares Biotechnology ETF position peaked at $5.97M in Q2 2016.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Jump Trading's 13F filing for Q3 2019, filed 12 Nov 2019.